Dijon. An information stand at the CHU on Wednesday for the National Day of Reflection on Organ Donation

Press Release of the CHU Dijon Burgundy

Wednesday, June 22, 2022: National Day of Reflection on Organ Donation and Transplantation and Donor Recognition

In 2020, the health crisis had a major impact on the number of transplants carried out in France, going from 5,897 in 2019 to 4,417. Thanks to the strong mobilization of healthcare professionals and their ability to adapt, activity has resumed the rise in 2021, with 5,276 transplants performed, an increase of 19.3% compared to the previous year. The mismatch between the number of available organs and patients awaiting transplant continues to grow.

Hospital coordination of organ and tissue retrieval

A service in its own right within the CHU Dijon Bourgogne, the hospital sampling coordination organizes the removal of organs and tissues from a deceased patient. It has an information and training role with health professionals and offers internal training for nurses and caregivers in intensive care and emergency services.

Donations in a few figures

• 60 patients received a kidney transplant at the CHU in 2021, which is one of the highest figures in recent years.

• In 2021, the average age of transplant patients was 54, the youngest was 19 and the oldest 79; we can indeed offer kidney transplantation to older patients if they are in good physical condition and after a complete assessment to rule out any contraindications.

• The kidney transplant can only work for a limited time, in particular because of the rejection phenomenon. The median survival in France is around 14 years, but some patients were transplanted in Dijon more than 40 years ago and their graft is still working!

Read also  The world's largest lesson encourages climate change

• In total since the creation of the kidney transplant team, 1675 patients have received a kidney transplant in Dijon. The first transplant was performed on June 6, 1973.

Since the creation of the Hospital Coordination of Samples of the CHU of Dijon in 1993, more than 750 patients in a state of brain death have been able to donate one or more organs allowing more than 2000 organ transplants in France. Collections from so-called Maastricht 3 donors have been in place in France since 2015 and at the CHU since July 2019. To date, 19 patients in this category have been collected at the CHU, thus allowing 37 transplants.

Who are the donors?

Organ and tissue removals can be performed from 4 types of donors:

 Deceased donors in a state of brain death: These are the most frequent organ donors from whom all the organs can be removed (the heart, the lungs, the liver, the kidneys, the pancreas, the intestines and also all tissues). The choice of organs to be removed is conditioned by a complete evaluation (imaging, biology, specialist opinions, etc.). There is no age limit.

Maastricht category III deceased donors: This concerns patients with cardiac arrest following a decision to stop therapy aged between 18 and 71 years.

Dee donors after persistent cardiac arrest

Living donors: Any adult, volunteer and in good health can donate a kidney or a hepatic lobe to a member of his family or very close circle. The most common living donor transplantation in France is kidney transplantation.

Anonymity and organ donation

Respect for anonymity between donor and recipient is one of the main principles to be respected in the activity of donation and transplantation. The rule of presumed consent, free donation, fairness in the proposal of grafts are the other fundamental principles. The relatives of a donor must in no way be able to identify the recipient(s); similarly, it must be impossible for the recipients of the donation to be able to know the identity of a donor and his relatives.

Read also  China has been buying (and storing) corn and wheat for months. Did you know about the invasion of Ukraine? -

All of the data collected by the sampling coordination team during the evaluation of a potential donor in an intensive care unit are sent to the Biomedicine Agency (ABM) so that it can validate the character transplantable organs safely. This Agency plays the role of intermediary between the two sides of the activity: removal and transplantation. It also guarantees complete data security and anonymity in exchanges between transplant patients and the donor’s family.